A STAT investigation explores how a new company is profiting from the arbitration process in the No Surprises Act.

A recent Epic lawsuit revealed a company allegedly posed as a provider to access patient records for law firms, prompting a ...

An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...

Doctronic, the startup behind a provocative experiment in Utah to renew drug prescriptions with a chatbot, has raised $40 ...

In today's Morning Rounds newsletter: the high-stakes search for a new CDC director, the impact of immigration policy on ...

New results on Pfizer's Lyme disease vaccine, how the Middle East conflict could strain drug supply chains, and more biotech ...

Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of ...

The decline of trust in health care in the U.S. has been ongoing and was worsened by the institutional responses to the Covid ...

An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used ...

Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung ...

The war in the Middle East so far has not appreciably disrupted pharmaceutical supply chains, but the conflict could do so as ...

A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...